Aventura Private Wealth’s Akero Therapeutics AKRO Stock Holding History

Aventura Private Wealth’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-131	Closed	-$6.22K	–	861
2025 Q3	$6.22K	Hold	131	–	–	﹤0.01%	556
2025 Q2	$6.99K	Hold	131	–	–	﹤0.01%	512
2025 Q1	$5.3K	Hold	131	–	–	﹤0.01%	526
2024 Q4	$3.64K	Buy	+131	New	+$3.97K	﹤0.01%	532

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aventura Private Wealth's AKRO Position: Q4 2025 in Review

Aventura Private Wealth sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 131 shares — an estimated $6.22K sold.

Aventura Private Wealth first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $6.99K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Aventura Private Wealth reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Aventura Private Wealth sold 131 Akero Therapeutics shares in Q4 2025, an estimated $6.22K.
Aventura Private Wealth first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
Aventura Private Wealth's Akero Therapeutics position peaked at $6.99K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Aventura Private Wealth's 13F filing for Q4 2025, filed 7 Jan 2026.